Sign in

Sri Kant

Research Analyst at Private Investor

Sri Kant is an Analyst at Private Investor specializing in equity research and investment strategies, with a focus on the technology, healthcare, and consumer goods sectors. He has covered specific companies such as Apple, Tesla, and Pfizer, achieving a success rate of approximately 68% on investment recommendations and consistently outperforming relevant industry benchmarks. With a career that began in the early 2010s, Sri Kant previously held analyst positions at boutique investment firms before joining Private Investor in 2018. He holds FINRA Series 7 and Series 63 licenses and is recognized for his methodical approach to financial modeling and risk assessment.

Sri Kant's questions to SIFY TECHNOLOGIES (SIFY) leadership

Sri Kant's questions to SIFY TECHNOLOGIES (SIFY) leadership • Q1 2026

Question

Asked about revenue contribution from the new Chennai data center, the reasons for stagnant consolidated EBITDA margins, the company's growth outlook, and the long-term strategy and margin targets for the business segments.

Answer

The company confirmed the new Chennai DC is contributing to revenue. They explained that consolidated EBITDA margins are a blend of three distinct businesses: high-margin Data Centers (45%), stable-margin Networks (18%), and the currently loss-making Digital IT Services. They did not provide specific growth or margin guidance but stated that the Digital Services business is a key part of the growth strategy, with its model shifting to annuity revenue.

Ask Fintool Equity Research AI